Oncology

Aspira Women’s Health Initiates Prospective Clinical Study for Benign Risk Monitoring and High Risk Early Ovarian Cancer Detection with Northwell Health

Aspira Women’s Health, a bioanalytical-based women’s health company focused on gynecologic disease and The Feinstein Institutes for Medical Research, the science arm of Northwell Health, the largest private Healthcare Provider in New York State, today announced the start of a prospective Clinical Study for Ovarian Cancer Risk Detection. Northwell Health treats over 2 million patients annually and employs over 16,000 credentialled physicians. The…

Roche Receives FDA Approval for the First Companion Diagnostic to Identify Endometrial Cancer Patients Eligible for Immunotherapy

Roche today announced U.S. Food and Drug Administration (FDA) approval of the VENTANA MMR RxDx Panel for advanced or recurrent endometrial cancer patients. MMR is a molecular mechanism that functions to correct certain errors that can spontaneously occur during DNA replication. Testing can identify patients eligible for treatment with JEMPERLI (dostarlimab-gxly) monotherapy, an anti-PD1 immunotherapy from GlaxoSmithKline (GSK) that was approved by…

Todos Medical Acquires Provista Diagnostics and Its Proprietary Videssa Breast Cancer Blood Test

Todos Medical, a comprehensive medical diagnostics and related solutions company, today announced that it has acquired Provista Diagnostics, Inc. Provista is a medical diagnostics company based in Alpharetta, Georgia that owns the intellectual property rights to the proprietary breast cancer blood test, Videssa, and has a diagnostic testing laboratory currently performing COVID-19 PCR testing, primarily for the medical and entertainment industries. The…

Israeli FemTech Company MobileODT Is Supporting a Large Scale Government Cervical Cancer Screening Project in the Dominican Republic

Israeli femtech company MobileODT, who are innovating in cervical cancer screening, have announced that their Visual Check AI technology is supporting a large-scale government cervical cancer screening project in the Dominican Republic. This proof of concept project was initiated as part of the company’s strategic direction in providing cervical cancer screening at scale, utilizing Artificial Intelligence (AI) and Machine Learning (ML) capabilities. The…

The Breast Cancer Alliance Celebrates Its 25th Anniversary

2021 marks 25 years since Breast Cancer Alliance (BCA) was formed, during which time the Connecticut-based foundation has grown into a national fundraising powerhouse for breast cancer research, breast surgery fellowships and outreach and education supporting patients in underserved communities. From its inception, BCA’s mission has been to improve survival rates and quality of life for those impacted by breast cancer through…

The FDA Accepts UVision360’s Submission for the Novel LUMINELLE DTx System Biopsy Sheath

UVision360 announced earlier today that the U.S. Food and Drug Administration (FDA) has accepted the Company’s submission to expand the LUMINELLE DTx System portfolio to now include the LUMINELLE 360° Bx (Biopsy) Sheath. The LUMINELLE DTx System, is a compact hysteroscopy and cystoscopy system, designed to meet the needs of patients and physicians in the office setting. The novel and patented LUMINELLE…

Hologic Completes Acquisition of Biotheranostics, Enabling Entry into Growing Oncology Market

Hologic, a global leader in women’s health, has completed its previously announced acquisition of molecular oncology leader Biotheranostics for approximately $230M. Biotheranostics develops and markets two highly differentiated molecular diagnostic tests for breast and metastatic cancers. “We are very pleased to complete the acquisition of Biotheranostics and look forward to working with our new colleagues to grow in the large, rapidly expanding oncology space,”…

Spain-based Endometrial Cancer Diagnostics Company MiMark Receives €1.5M Investment from EIT Health

Barcelona-based company MiMARK has received €1.5M in funding from EIT Health following the EIT Health Wild Card program. The company is working on improving accuracy and efficiency of diagnostics for endometrial cancer. Abnormal vaginal bleeding affects 9M women in EU and US yearly. Diagnosis of endometrial cancer is mandatory since 10% of these women will suffer it. Current diagnosis is based on the pathological…